Skip to main content
BrainCited

Uridine Monophosphate for Neurotransmitter Imbalance

C Some Evidence Limited evidence from small studies, but some positive signals exist.

The uridine + DHA + choline combination (known as the 'Mr. Happy Stack') provides synergistic support for phospholipid synthesis and dopamine receptor expression. Limited but promising clinical evidence.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Duridine\u002Dmonophosphate\u0026condition\u003Dneurotransmitter\u002Dimbalance'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

The Bottom Line

The uridine + DHA + choline combination (known as the 'Mr. Happy Stack') provides synergistic support for phospholipid synthesis and dopamine receptor expression. Limited but promising clinical evidence.

Key Study Findings

In Vitro
The Effects of Semen Ziziphi Spinosae Extract on LPS-Induced Astrocyte Gene Expression and Metabolites.
Dose: None vs: LPS-treated astrocyte controls Outcome: Astrocyte gene expression and metabolite changes Effect: None None

Population: LPS-induced inflammatory astrocyte model

Observational Study
Combining Metabolomics and Proteomics to Reveal Key Serum Compounds Related to Canine Intervertebral Disc Herniation.
Dose: None vs: None Outcome: None Effect: None None

Population: Dogs with intervertebral disc herniation

Review
Involvement of uridine in brain and gut health: insights into its neuroprotective potential via the …
Dose: None vs: None Outcome: None Effect: None None

Population: None

Other 4 weeks
Jujuboside A Regulates Calcium Homeostasis and Structural Plasticity to Alleviate Depression-Like Behavior via Shh Signaling …
Dose: 5 mg/kg vs: None Outcome: Cognitive function Effect: None None

Population: Sprague Dawley rats

Other
1H and 31P magnetic resonance spectroscopy reveals potential pathogenic and biomarker metabolite alterations in Lafora …
Dose: None vs: None Outcome: None Effect: None P = 0.013

Population: Healthy adults

Review
Citicoline for Supporting Memory in Aging Humans.
Dose: None vs: placebo Outcome: cognitive function Effect: None None

Population: Mild cognitive impairment and some other neurological diseases

Key Statistics

4

Studies

300

Participants

Positive

C

Grade

Referenced Papers

Aging and disease 2023 9 citations
Clinical pharmacokinetics 2018 128 citations
Autonomic neuroscience : … 2015 81 citations
European journal of … 2011 16 citations
Annual review of … 2009 141 citations
The European journal … 2007 55 citations
Journal of neuroscience … 1996 16 citations
Behavioural brain research 1995 146 citations
Journal of steroid … 1984 22 citations

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Commonly Used Dosages

general:
150-250 mg/day
cognitivesupport:
250-500 mg sublingually

Upper limit: Not established; well-tolerated up to 1,000 mg/day

Dosages Studied in Research

Dosage Duration Effect N
None -- Positive --
None -- Mixed --
None -- Mixed --
5 mg/kg 4 weeks Positive --
None -- Neutral --
None -- Mixed --
1 g -- Mixed --
None -- Mixed --

Best taken: Morning; synergizes with DHA and choline sources

Safety & Side Effects

Reported Side Effects

  • Mild gastrointestinal discomfort
  • Headache (rare)
  • Nervousness at high doses

Known Interactions

  • No significant drug interactions established

Tolerable upper intake: Not established; well-tolerated up to 1,000 mg/day

Always consult your healthcare provider before starting any supplement.

Frequently Asked Questions

Does Uridine Monophosphate help with Neurotransmitter Imbalance?
Based on 4 studies with 300 participants, there is limited but promising evidence that Uridine Monophosphate may support Neurotransmitter Imbalance management. Our evidence grade is C (Some Evidence).
How much Uridine Monophosphate should I take for Neurotransmitter Imbalance?
Studies have used various dosages. A commonly studied range is 150-250 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Uridine Monophosphate?
Reported side effects may include Mild gastrointestinal discomfort, Headache (rare), Nervousness at high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Uridine Monophosphate and Neurotransmitter Imbalance?
We rate the evidence as Grade C (Some Evidence). This rating is based on 4 peer-reviewed studies with 300 total participants. The overall direction of effect is positive.

Other ingredients for Neurotransmitter Imbalance

References

  1. [1] Anita Horvatić et al.. Metabolites. 2025. Combining Metabolomics and Proteomics to Reveal Key Serum Compounds Related to Canine Intervertebral Disc Herniation. doi:10.3390/metabo15060396 PubMed
  2. [2] Jingxuan Ma et al.. Nutrients. 2025. The Effects of Semen Ziziphi Spinosae Extract on LPS-Induced Astrocyte Gene Expression and Metabolites. doi:10.3390/nu17223498 PubMed
  3. [3] Birnur Aydin et al.. Pharmacol Rep. 2025. Involvement of uridine in brain and gut health: insights into its neuroprotective potential via the gut-brain axis. doi:10.1007/s43440-025-00788-5 PubMed
  4. [4] Ziyan Zhong et al.. Drug Des Devel Ther. 2024. Jujuboside A Regulates Calcium Homeostasis and Structural Plasticity to Alleviate Depression-Like Behavior via Shh Signaling in Immature Neurons. doi:10.2147/DDDT.S479055 PubMed
  5. [5] Kimberly L Chan et al.. Brain Commun. 2024. 1H and 31P magnetic resonance spectroscopy reveals potential pathogenic and biomarker metabolite alterations in Lafora disease. doi:10.1093/braincomms/fcae104 PubMed
  6. [6] Lanmei Wang et al.. Int J Mol Sci. 2023. Integrated Analysis of Transcriptomics and Metabolomics Unveil the Novel Insight of One-Year-Old Precocious Mechanism in the Chinese Mitten Crab, Eriocheir … doi:10.3390/ijms241311171 PubMed
  7. [7] Maciej Świątkiewicz et al.. Aging Dis. 2023. Citicoline for Supporting Memory in Aging Humans. doi:10.14336/AD.2022.0913 PubMed
  8. [8] Caley A Hogan et al.. EMBO Rep. 2023. Expanded tRNA methyltransferase family member TRMT9B regulates synaptic growth and function. doi:10.15252/embr.202356808 PubMed
  9. [9] Sreyashi Samaddar et al.. Int J Mol Sci. 2022. The G Protein-Coupled Serotonin 1A Receptor Augments Protein Kinase Cε-Mediated Neurogenesis in Neonatal Mouse Hippocampus-PKCε-Mediated Signaling in the Early Hippocampus. doi:10.3390/ijms23041962 PubMed
  10. [10] Pengtao Xu et al.. Neurochem Int. 2021. Region-specific metabolic characterization of the type 1 diabetic brain in mice with and without cognitive impairment. doi:10.1016/j.neuint.2020.104941 PubMed
  11. [11] Charles Kennedy. Auton Neurosci. 2021. ATP as a cotransmitter in sympathetic and parasympathetic nerves - another Burnstock legacy. doi:10.1016/j.autneu.2021.102860 PubMed
  12. [12] Lina A Dahabiyeh et al.. Metabolites. 2020. Dexamethasone-Induced Perturbations in Tissue Metabolomics Revealed by Chemical Isotope Labeling LC-MS analysis. doi:10.3390/metabo10020042 PubMed
  13. [13] Grace Chen et al.. Clin Pharmacokinet. 2018. Vortioxetine: Clinical Pharmacokinetics and Drug Interactions. doi:10.1007/s40262-017-0612-7 PubMed
  14. [14] Leonie Durnin et al.. Am J Physiol Gastrointest Liver Physiol. 2017. Loss of nitric oxide-mediated inhibition of purine neurotransmitter release in the colon in the absence of interstitial cells of Cajal. doi:10.1152/ajpgi.00045.2017 PubMed
  15. [15] Richard J Wurtman. Eur J Pharmacol. 2017. Synapse formation in the brain can be enhanced by co-administering three specific nutrients. doi:10.1016/j.ejphar.2017.09.038 PubMed
  16. [16] Zacharias Kohl et al.. Neurobiol Dis. 2016. Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC α-synuclein transgenic rat model of Parkinson's disease. doi:10.1016/j.nbd.2015.10.021 PubMed
  17. [17] Vera Ralevic et al.. Auton Neurosci. 2015. Purinergic transmission in blood vessels. doi:10.1016/j.autneu.2015.04.007 PubMed
  18. [18] Tushar K Bhattacharya et al.. Physiol Behav. 2015. Exercise but not (-)-epigallocatechin-3-gallate or β-alanine enhances physical fitness, brain plasticity, and behavioral performance in mice. doi:10.1016/j.physbeh.2015.03.023 PubMed
  19. [19] Morag J Andrew et al.. BMC Pediatr. 2015. Optimising nutrition to improve growth and reduce neurodisabilities in neonates at risk of neurological impairment, and children with suspected or … doi:10.1186/s12887-015-0339-2 PubMed
  20. [20] Ove Lundgren et al.. PLoS One. 2011. Intestinal epithelial stem/progenitor cells are controlled by mucosal afferent nerves. doi:10.1371/journal.pone.0016295 PubMed
  21. [21] Richard J Wurtman. Eur J Pharmacol. 2011. Non-nutritional uses of nutrients. doi:10.1016/j.ejphar.2011.07.005 PubMed
  22. [22] Weigang Gu et al.. Stem Cell Res. 2010. Neurotransmitter synthesis in poststroke cortical neurogenesis in adult rats. doi:10.1016/j.scr.2009.12.001 PubMed
  23. [23] Beate Winner et al.. Exp Neurol. 2009. Dopamine receptor activation promotes adult neurogenesis in an acute Parkinson model. doi:10.1016/j.expneurol.2009.07.013 PubMed
  24. [24] Richard J Wurtman et al.. Annu Rev Nutr. 2009. Use of phosphatide precursors to promote synaptogenesis. doi:10.1146/annurev-nutr-080508-141059 PubMed
  25. [25] Mehmet Cansev et al.. Alzheimers Dement. 2008. Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses. doi:10.1016/j.jalz.2007.10.005 PubMed
  26. [26] Sarah Holguin et al.. FASEB J. 2008. Dietary uridine enhances the improvement in learning and memory produced by administering DHA to gerbils. doi:10.1096/fj.08-112425 PubMed
  27. [27] Anayansi Molina-Hernández et al.. J Neurochem. 2008. Histamine induces neural stem cell proliferation and neuronal differentiation by activation of distinct histamine receptors. doi:10.1111/j.1471-4159.2008.05424.x PubMed
  28. [28] Myung-Min Choi et al.. Biotechnol Appl Biochem. 2008. Small-interfering-RNA-mediated silencing of human glutamate dehydrogenase induces apoptosis in neuroblastoma cells. doi:10.1042/BA20070190 PubMed
  29. [29] Sophie Scotto-Lomassese et al.. Eur J Neurosci. 2007. HVC interneurons are not renewed in adult male zebra finches. doi:10.1111/j.1460-9568.2007.05418.x PubMed
  30. [30] Keely M Bumsted-O'Brien et al.. J Comp Neurol. 2007. Expression of the homeodomain transcription factor Meis2 in the embryonic and postnatal retina. doi:10.1002/cne.21458 PubMed
  31. [31] Lei Wang et al.. J Mol Neurosci. 2005. Dietary uridine-5'-monophosphate supplementation increases potassium-evoked dopamine release and promotes neurite outgrowth in aged rats. doi:10.1385/JMN:27:1:137 PubMed
  32. [32] Laszlo Köles et al.. Drug News Perspect. 2005. P2X and P2Y receptors as possible targets of therapeutic manipulations in CNS illnesses. doi:10.1358/dnp.2005.18.2.886479 PubMed
  33. [33] Marisa L Kreider et al.. Neuropsychopharmacology. 2005. Disruption of rat forebrain development by glucocorticoids: critical perinatal periods for effects on neural cell acquisition and on cell signaling … doi:10.1038/sj.npp.1300743 PubMed
  34. [34] H Jørgensen et al.. J Neuroendocrinol. 2002. Serotonergic stimulation of corticotropin-releasing hormone and pro-opiomelanocortin gene expression. doi:10.1046/j.1365-2826.2002.00839.x PubMed
  35. [35] A Martínez-Contreras et al.. J Neurosci Res. 2002. Astrocytic and microglia cells reactivity induced by neonatal administration of glutamate in cerebral cortex of the adult rats. doi:10.1002/jnr.10093 PubMed
  36. [36] Lynette D Fairbanks et al.. Biochem J. 2002. Severe pyridine nucleotide depletion in fibroblasts from Lesch-Nyhan patients. doi:10.1042/BJ20020148 PubMed
  37. [37] Andrei B Belousov et al.. J Neurophysiol. 2002. Calcium-dependent regulation of cholinergic cell phenotype in the hypothalamus in vitro. doi:10.1152/jn.2002.88.3.1352 PubMed
  38. [38] Francesco Fornai et al.. Funct Neurol. 2002. Is there a role for uridine and pyrimidine nucleosides in the treatment of vascular dementia? PubMed
  39. [39] D R Piper et al.. J Neurosci Res. 2001. Identification and characterization of neuronal precursors and their progeny from human fetal tissue. doi:10.1002/jnr.1228 PubMed
  40. [40] W Mayo et al.. Horm Behav. 2001. Pregnenolone sulfate and aging of cognitive functions: behavioral, neurochemical, and morphological investigations. doi:10.1006/hbeh.2001.1677 PubMed
  41. [41] L Studer et al.. J Neurosci. 2000. Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. doi:10.1523/JNEUROSCI.20-19-07377.2000 PubMed
  42. [42] C J Tai et al.. J Clin Endocrinol Metab. 2000. Expression and regulation of P2U-purinergic receptor in human granulosa-luteal cells. doi:10.1210/jcem.85.4.6558 PubMed
  43. [43] J Kardos et al.. Neuroreport. 1999. Uridine activates fast transmembrane Ca2+ ion fluxes in rat brain homogenates. doi:10.1097/00001756-199905140-00034 PubMed
  44. [44] W Ma et al.. Microsc Res Tech. 1998. GABA, GAD, and GABA(A) receptor alpha4, beta1, and gamma1 subunits are expressed in the late embryonic and early postnatal neocortical … doi:10.1002/(SICI)1097-0029(19980301)40:5<398::AID-JEMT6>3.0.CO;2-N PubMed
  45. [45] J J Park et al.. J Neurobiol. 1996. Neurogenesis and cell migration into the sexually dimorphic preoptic area/anterior hypothalamus of the fetal ferret. doi:10.1002/(SICI)1097-4695(199607)30:3<315::AID-NEU1>3.0.CO;2-7 PubMed
  46. [46] K D Moore et al.. Mol Chem Neuropathol. 1996. In vitro properties of a newly established medulloblastoma cell line, MCD-1. doi:10.1007/BF02814996 PubMed
  47. [47] S Kentroti et al.. J Neurosci Res. 1996. Ethanol neurotoxicity in culture: selective loss of cholinergic neurons. doi:10.1002/(SICI)1097-4547(19960615)44:6<577::AID-JNR8>3.0.CO;2-8 PubMed
  48. [48] S Inoué et al.. Behav Brain Res. 1995. Sleep as neuronal detoxification and restitution. doi:10.1016/0166-4328(95)00014-k PubMed
  49. [49] P J Lein et al.. Dev Biol. 1989. Laminin and a basement membrane extract have different effects on axonal and dendritic outgrowth from embryonic rat sympathetic neurons in … doi:10.1016/0012-1606(89)90260-1 PubMed
  50. [50] E R de Kloet. J Steroid Biochem. 1984. Adrenal steroids as modulators of nerve cell function. doi:10.1016/0022-4731(84)90204-8 PubMed
  51. [51] E W Godfrey et al.. Brain Res. 1975. Neurons from fetal rat brain in a new cell culture system: a multidisciplinary analysis. doi:10.1016/0006-8993(75)90679-4 PubMed

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.